Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02324621
What this trial is testing

Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor
Rutgers, The State University of New Jersey 26
Early research (Phase 1)Study completedNCT01206816
What this trial is testing

An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 (Volasertib)in Combination With Oral BIBW 2992 (Afatinib) in Patients With Advanced Solid Tumours

Who this might be right for
Neoplasms
Boehringer Ingelheim 57
Early research (Phase 1)Study completedNCT04134312
What this trial is testing

Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer

Who this might be right for
Solid Metastatic Tumor
Bavarian Nordic 13
Early research (Phase 1)WithdrawnNCT06341647
What this trial is testing

Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201

Who this might be right for
Breast CancerGastric CancerGastroesophageal Junction Adenocarcinoma
GC Cell Corporation
Early research (Phase 1)Ended earlyNCT01127178
What this trial is testing

Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Eisai Inc. 12
Early research (Phase 1)Study completedNCT00007917
What this trial is testing

Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 58
Early research (Phase 1)Study completedNCT02278250
What this trial is testing

First in Human Study of M4344 in Participants With Advanced Solid Tumors

Who this might be right for
Solid TumorAdvanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 97
Testing effectiveness (Phase 2)Study completedNCT02598960
What this trial is testing

An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.

Who this might be right for
Solid Tumors
Bristol-Myers Squibb 295
Early research (Phase 1)Study completedNCT00692159
What this trial is testing

Study of TRC102 in Combination With Pemetrexed in Cancer Patients

Who this might be right for
Neoplasm
Tracon Pharmaceuticals Inc. 28
Early research (Phase 1)Ended earlyNCT06509906
What this trial is testing

M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 3
Early research (Phase 1)Study completedNCT00487058
What this trial is testing

A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Novartis 28
Early research (Phase 1)Study completedNCT05990920
What this trial is testing

Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy

Who this might be right for
Pathologically Confirmed Cancer Refractory to Conventional TherapyRefractory CancerMetastatic Cancer+5 more
NKGen Biotech, Inc. 6
Early research (Phase 1)Study completedNCT02219724
What this trial is testing

Assess Safety and Pharmacokinetics of MOXR0916 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Neoplasms
Genentech, Inc. 174
Early research (Phase 1)Study completedNCT00338182
What this trial is testing

AZD1152 in Patients With Advanced Solid Malignancies

Who this might be right for
Tumors
AstraZeneca 43
Early research (Phase 1)Study completedNCT01155258
What this trial is testing

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
University of Southern California 19
Early research (Phase 1)Study completedNCT02076620
What this trial is testing

L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumors Amenable to Anthracycline TherapySarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy
Philogen S.p.A. 29
Early research (Phase 1)Active Not RecruitingNCT03875820
What this trial is testing

Phase I Trial of Defactinib and VS-6766.

Who this might be right for
NSCLCLow Grade Serous Ovarian CancerEndometrioid Carcinoma+1 more
Institute of Cancer Research, United Kingdom 87
Early research (Phase 1)Active Not RecruitingNCT05082259
What this trial is testing

ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab

Who this might be right for
Advanced CancerCervical CancerTriple Negative Breast Cancer
Institute of Cancer Research, United Kingdom 61
Early research (Phase 1)Study completedNCT00635778
What this trial is testing

A Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002)

Who this might be right for
Advanced Solid Tumors
Merck Sharp & Dohme LLC 50
Early research (Phase 1)Looking for participantsNCT05881525
What this trial is testing

NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
TCRCure Biopharma Ltd. 18
Next Page